Search research articles
Contact Us
Filters
Showing results (181-190 of 205) with videos related to
Page
of 21
Sort By:
Nature Genetics
|
May 6, 2014
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations
Shinji Kohsaka, Neerav Shukla, Nabahet Ameur, et al.
Oncotarget
|
February 26, 2014
Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition
Chueh-Chuan Yen, Chung-Der Hsiao, Wei-Ming Chen, et al.
International Journal of Oncology
|
September 3, 2009
Identification of chromosomal aberrations associated with disease progression and a novel 3q13.31 deletion involving LSAMP gene in osteosarcoma
Chueh-Chuan Yen, Wei-Ming Chen, Tain-Hsiung Chen, et al.
Blood
|
March 20, 2010
Discovery of a small-molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFRalpha, Kit, and Src kinases: novel type II inhibitor of gatekeeper mutants
Ellen Weisberg, Hwan Geun Choi, Arghya Ray, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 28, 2004
PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder
Jing Chen, Daniel J Deangelo, Jeffery L Kutok, et al.
Cancers
|
September 27, 2025
Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy Breakout
Jacqueline Oliva-Ramirez, David Milewski, Lauren Banks, et al.
Nature Genetics
|
May 6, 2014
Dystrophin is a tumor suppressor in human cancers with myogenic programs
Yuexiang Wang, Adrian Marino-Enriquez, Richard R Bennett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2003
Soft tissue sarcomas of adults: state of the translational science
Ernest C Borden, Laurence H Baker, Robert S Bell, et al.
The Journal of Experimental Medicine
|
June 18, 2021
E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non-small cell lung cancer
Ke Li, Xufen Zheng, Hua Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2015
Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition
Richard D Carvajal, Donald P Lawrence, Jeffrey S Weber, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 205) with videos related to
Sort By:
Page
of 21
Nature Genetics
|
May 6, 2014
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations
Shinji Kohsaka, Neerav Shukla, Nabahet Ameur, et al.
Oncotarget
|
February 26, 2014
Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition
Chueh-Chuan Yen, Chung-Der Hsiao, Wei-Ming Chen, et al.
International Journal of Oncology
|
September 3, 2009
Identification of chromosomal aberrations associated with disease progression and a novel 3q13.31 deletion involving LSAMP gene in osteosarcoma
Chueh-Chuan Yen, Wei-Ming Chen, Tain-Hsiung Chen, et al.
Blood
|
March 20, 2010
Discovery of a small-molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFRalpha, Kit, and Src kinases: novel type II inhibitor of gatekeeper mutants
Ellen Weisberg, Hwan Geun Choi, Arghya Ray, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 28, 2004
PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder
Jing Chen, Daniel J Deangelo, Jeffery L Kutok, et al.
Cancers
|
September 27, 2025
Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy Breakout
Jacqueline Oliva-Ramirez, David Milewski, Lauren Banks, et al.
Nature Genetics
|
May 6, 2014
Dystrophin is a tumor suppressor in human cancers with myogenic programs
Yuexiang Wang, Adrian Marino-Enriquez, Richard R Bennett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2003
Soft tissue sarcomas of adults: state of the translational science
Ernest C Borden, Laurence H Baker, Robert S Bell, et al.
The Journal of Experimental Medicine
|
June 18, 2021
E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non-small cell lung cancer
Ke Li, Xufen Zheng, Hua Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2015
Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition
Richard D Carvajal, Donald P Lawrence, Jeffrey S Weber, et al.
Page
of 21